Heather Cloud, R-Turkey Creek, said the state should explore creative solution to bringing down the costs of covering GLP-1 drugs in health insurance plans.(Greg LaRose/Louisiana Illuminator) Expenses have surged for Louisianas public worker health insurance plans as more people are prescribed GLP-1 drugs, known by brand names such as Ozempic and Mounjaro
Some of the most dangerous side effects associated with GLP-1 agonists are poorly documented, often to the point that patients receive little to no warning of the potential danger
declare no competing interest
This results in decreased appetite and reduced caloric intake
The answer is simple
Permitted substance does not always mean permitted method. If you are drug-tested, check Global DRO, your sport policy, and your national anti-doping organization before using injections, IV clinics, or compounded products